retatrutide glp-1 Retatrutide: The "Triple G" Peptide That Could Rival Bariatric Surgery (And Why You Shouldn't Wait) Doctor Reveals The BEST GLP-1

Of that 15-20% reduction in bodyweight, 25-40% of that amount can be expected to be losses in muscle mass and lean tissue - I don't need to tell you why this is a bad thing

How Retatrutide Compares to Current GLP1 and DualAgonist Drugs Current injectable weightloss drugs can be grouped roughly as: GLP1 single agonists semaglutide (Ozempic, Wegovy), liraglutide, etc

I've had a long experience with transforming people's lives by getting them to bariatric surgery, what we call metabolic surgery

This strategy reduces the dosing frequency from daily to three times per year and has the potential to significantly enhance patient compliance [138]